Skip to content

Study on the management intervention of clinical chronic disease assisted by medicine-food homologous functional food

Clinical study on the intervention of medical-food homologous functional food in metabolic syndrome

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066645
Enrollment
Unknown
Registered
2022-12-12
Start date
2022-11-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Non-Communicable Diseases

Interventions

The Tartary buckwheat tea group:Drinking Tartary buckwheat tea and regular dietary care
Tartary buckwheat diet therapy group:Tartary buckwheat tea combined with a modified Mediterranean diet

Sponsors

First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) 24kg/m2=BMI=32.0kg/m2, clearly diagnosed as overweight or obesity. (2) Aged 18-75, both sexes. (3) Diagnosis of dyslipidemia: Serum total cholesterol (TC)=5.20mmol/L (200mg/dl) and/or triglycerides (TG) =1.70mmol/L (150mg/dl) and/or low-density lipoprotein cholesterol (LDL-C)= 3.40mmol/l (130mg/dl) and/or high-density lipoprotein cholesterol (HD) L-c) =1.0mmol/l (40mg/dl) is the standard, meeting one of the above conditions;

Exclusion criteria

Exclusion criteria: (1) Suffering from digestive system diseases, impaired function of vital organs (liver, lung, kidney) or other serious chronic diseases (such as inflammation and infection, connective tissue lesions or malignant tumors, etc.); (2) suffer from growth hormone deficiency or other important endocrine diseases, such as thyroid disease; (3) Patients with type 1 diabetes mellitus, gestational diabetes mellitus, and those taking insulin; (4) Special types of fatty liver: fatty liver caused by certain drugs and environmental toxins; (5) Patients with acute gouty arthritis or refractory gout. (6) Taking niacin, cyclosporine, aspirin, furosemide, hydrochlorothiazide, quinolones, penicillin and other drugs that affect uric acid excretion.

Design outcomes

Primary

MeasureTime frame
Biochemical metabolic index;

Secondary

MeasureTime frame
Intestinal flora;The quality of life;Healthy Diet index;Depressive symptom;Height, weight, waist, hip circumference;

Countries

China

Contacts

Public ContactHan Shifan

First Hospital of Shanxi Medical University

shifan.han@sxmu.edu.cn+86 13903409675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026